Clinical Trial Update: The Effects of Dihydromiricetin on MASLD [NA]

View source ↗

Summary

A clinical trial evaluating Dihydromiricetin for nonalcoholic fatty liver disease (MASLD) has completed, according to ClinicalTrials.gov, sponsored by the Unive…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Metabolic Dysfunction-associated Steatotic Liver Disease
• Nonalcoholic Fatty Liver Disease

Drugs mentioned

• Dihydromiricetin (dihydromiricetin)

Snippet

Sponsor: University of Athens | Conditions: NAFLD | NA | Status: COMPLETED